Orchestra BioMed Holdings, Inc.
OBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $22 | $31 | $20 | $10 |
| Short-Term Investments | $45 | $57 | $64 | $1 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $1 | $1 | $0 |
| Total Curr. Assets | $69 | $89 | $85 | $11 |
| Property Plant & Equip (Net) | $3 | $3 | $4 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2 | $2 | $2 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $5 | $1 |
| Total NC Assets | $7 | $6 | $11 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $76 | $95 | $96 | $14 |
| Liabilities | – | – | – | – |
| Payables | $5 | $3 | $4 | $2 |
| Short-Term Debt | $1 | $1 | $1 | $2 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $4 | $3 | $6 | $6 |
| Other Curr. Liab. | $6 | $5 | $7 | $3 |
| Total Curr. Liab. | $16 | $11 | $19 | $12 |
| LT Debt | $16 | $1 | $11 | $4 |
| Deferred Rev, NC | $11 | $15 | $13 | $17 |
| Deferred Tax Liab, NC | $0 | -$15 | $0 | $0 |
| Other NC Liab. | $0 | $15 | $0 | $52 |
| Total NC Liab. | $27 | $16 | $24 | $73 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $2 | $0 |
| Total Liabilities | $43 | $27 | $43 | $85 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $51 |
| Common Stock | $0 | $0 | $0 | $160 |
| Retained Earnings | -$310 | -$249 | -$200 | -$166 |
| AOCI | $0 | -$0 | -$0 | -$211 |
| Other Equity | $343 | $317 | $252 | $95 |
| Total Equity | $33 | $68 | $53 | -$71 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $76 | $95 | $96 | $14 |
| Net Debt | -$6 | -$29 | -$8 | -$4 |